Mr Todd Swarthout

Senior Research Fellow - Epidemiology

Division of Infection and Immunity
University College London

Areas of interest

Todd Swarthout is an infectious diseases epidemiologist. His research interests are in understanding how to optimise vaccine schedules to reduce the burden of vaccine-preventable diseases in low-resourced high mortality settings, how best to protect vulnerable groups, and how to optimise methods to evaluate vaccine impact and effectiveness.


Todd obtained his MSc (Public Health in Developing Countries) from the London School of Hygiene and Tropical Medicine in 2001. He subsequently worked 12 years with M├ędecins Sans Frontiers (MSF) and M├ędecins du Monde (MDM), including 7 years as field epidemiologist and clinical trial leader (locations including the Democratic Republic of Congo, Sudan, Zimbabwe and Nigeria) and 5 years as Senior Health Advisor and emergency/outbreak epidemiologist during headquarter postings in Paris and Amsterdam. He subsequently worked for 2 years in Amsterdam with Novartis Vaccines, leading the epidemiology portfolio in work to develop a GBS vaccine. Prior to joining UCL, Todd worked with the Liverpool School of Tropical Medicine, based in Malawi with the Malawi-Liverpool-Wellcome Trust Clinical Research Programme. With UCL, Todd will continue the vaccines work he started with LSTM, leading a number of projects, including the PAVE study. PAVE is a 4-year BMGF-funded programme to evaluate the impact of an alternative WHO-approved PCV13 vaccine schedule in Blantyre District, Malawi.